Woodland, CA, United States of America

James S Cullor

This inventor holds 10 USPTO granted patents. Top assignees: University of California, Other. Active years: 1985-2001.


% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 5

Forward Citations = 237(Granted Patents)


Company Filing History:


Years Active: 1985-2001

Loading Chart...
10 patents (USPTO):Explore Patents

Title: Innovations of James S. Cullor

Introduction

James S. Cullor is a notable inventor based in Woodland, CA (US). He has made significant contributions to the field of biotechnology, particularly in the areas of pathogen inactivation and disease prevention. With a total of 10 patents to his name, Cullor's work has had a profound impact on public health and veterinary medicine.

Latest Patents

Among his latest patents is a method for laser inactivation of infectious agents. This innovative approach utilizes UV radiation, specifically through lasers, to effectively inactivate pathogens such as viruses in biological materials. Another significant invention is a vaccine against papillomatous digital dermatitis (PDD). This invention focuses on the diagnosis and prevention of diseases in ungulates caused by the spirochete bacteria Treponema, involving isolated cultures and nucleic acids.

Career Highlights

Cullor has had a distinguished career, working with esteemed institutions such as the University of California. His research and inventions have contributed to advancements in both human and animal health, showcasing his commitment to improving disease management.

Collaborations

Throughout his career, Cullor has collaborated with notable individuals, including Michael E. Selsted and David W. Hird. These partnerships have further enhanced the impact of his innovations in the scientific community.

Conclusion

James S. Cullor's contributions to biotechnology through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to influence advancements in health and disease prevention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…